» Articles » PMID: 34297424

Estimating Risk Factor Progression Equations for the UKPDS Outcomes Model 2 (UKPDS 90)

Overview
Journal Diabet Med
Specialty Endocrinology
Date 2021 Jul 23
PMID 34297424
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To estimate 13 equations that predict clinically plausible risk factor time paths to inform the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model version 2 (UKPDS-OM2).

Methods: Data from 5102 UKPDS participants from the 20-year trial, and the 4031 survivors with 10 years further post-trial follow-up, were used to derive equations for the time paths of 13 clinical risk factors: HbA , systolic blood pressure, LDL-cholesterol, HDL-cholesterol, BMI, micro- or macro-albuminuria, creatinine, heart rate, white blood cell count, haemoglobin, estimated glomerular filter rate, atrial fibrillation and peripheral vascular disease (PVD). The incidence of events and death predicted by the UKPDS-OM2 when informed by the new risk factor equations was compared with the observed cumulative rates up to 25 years.

Results: The new equations were based on 24 years of follow-up and up to 65,252 person-years of data. Women were associated with higher values of all continuous risk factors except for haemoglobin. Older age and higher BMI at diagnosis were associated with higher rates of PVD (HR 1.06 and 1.02), atrial fibrillation (HR 1.10 and 1.08) and micro- or macro-albuminuria (HR 1.01 and 1.18). Smoking was associated with higher rates of developing PVD (HR 2.38) and micro- and macro-albuminuria (HR 1.39). The UKPDS-OM2, informed by the new risk factor equations, predicted event rates for complications and death consistent with those observed.

Conclusions: The new equations allow risk factor time paths beyond observed data, which should improve modelling of long-term health outcomes for people with type 2 diabetes when using the UKPDS-OM2 or other models.

Citing Articles

Relationship of cardiorenal risk factors with albuminuria based on age, smoking, glycaemic status and BMI: a retrospective cohort study of the UK Biobank data.

Kar D, El-Wazir A, Nath M, Breeze P, Jetha K, Strong M BMJ Public Health. 2025; 1(1):e000172.

PMID: 40017893 PMC: 11812708. DOI: 10.1136/bmjph-2023-000172.


The Long-Term Cost-Effectiveness of Oral Semaglutide Versus Lower-Cost Liraglutide in the UK.

Elnaggar M, Mansinho J, Malkin S, Whitaker J, Hunt B, Glah D Diabetes Ther. 2025; .

PMID: 39969755 DOI: 10.1007/s13300-025-01691-1.


A model based cost-utility analysis of Embedding referral to structured self-management education into standard practice (Embedding) compared to usual care for people with type 2 diabetes diagnosis in the last 12 months in England.

Pollard D, Keetharuth A, Brennan A, Bodicoat D, Glab A, Hadjiconstantinou M BMJ Open. 2025; 15(2):e093327.

PMID: 39933817 PMC: 11815453. DOI: 10.1136/bmjopen-2024-093327.


Improving outcomes with early and intensive metabolic control in patients with type 2 diabetes: a long-term modeling analysis of clinical and cost outcomes in Italy.

Arietti P, Boye K, Guidi M, Rachman J, Federici M, Raiola R J Diabetes Metab Disord. 2025; 24(1):58.

PMID: 39886102 PMC: 11780239. DOI: 10.1007/s40200-024-01553-w.


Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent....

Mueller J, Breeze P, Fusco F, Sharp S, Pidd K, Brennan A Diabetologia. 2025; .

PMID: 39849151 DOI: 10.1007/s00125-024-06355-6.